Article
Sulfonylureas target the neurovascular response to decrease Alzheimer’s pathology
medRxiv · 2021 · Macauley, S. L.; Stanley, M.; Caesar, E. E.; Moritz, W. R.; Bice, A. R.; Cruz-Diaz, N.; Carroll, C. M.; Day, S. M.; Grizzanti, J.; Mahan, T. E.; Snipes, J. A.; Orr, T. C.; Culver, J.; Remedi, M. S.; Nichols, C. G.; Karch, C.; Cox, L. A.; Diz, D. I.; Bauer, A. Q.; Holtzman, D. M.
Key facts
| Title | Sulfonylureas target the neurovascular response to decrease Alzheimer’s pathology |
|---|---|
| First author | Macauley, S. L.; Stanley, M.; Caesar, E. E.; Moritz, W. R.; Bice, A. R.; Cruz-Diaz, N.; Carroll, C. M.; Day, S. M.; Grizzanti, J.; Mahan, T. E.; Snipes, J. A.; Orr, T. C.; Culver, J.; Remedi, M. S.; Nichols, C. G.; Karch, C.; Cox, L. A.; Diz, D. I.; Bauer, A. Q.; Holtzman, D. M. |
| Journal | medRxiv |
| Published | Aug 12, 2021 |
| DOI | 10.1101/2021.08.11.455969 |
| Devices mentioned | K133972, K142003, K170858, K191495, K192440, K192932, K212956, K213883, K233027, K912666, K950905, K960464 |
| Product codes mentioned | EMA, IZH, IZL, KLE, LIQ, MQB, MUE, OWB, PSY, JAA, JJH |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1